Table 5.
ROIs | Diffusion Measure | N | β | p-value | |
---|---|---|---|---|---|
SM/Cer C16:0 | |||||
- | - | - | - | - | |
SM/Cer C18:0 | |||||
- | - | - | - | - | |
SM/Cer C20:0 | |||||
- | - | - | - | - | |
SM/Cer C22:0 | |||||
SCR | FA | 141 | 4.41E-03 | 0.044 | |
PCR | FA | 141 | 4.80E-03 | 0.017 | |
SM/Cer C22:1 | |||||
CH | FA | 150 | 2.91E-05 | 0.016 | |
SM/Cer C24:0 | |||||
ALIC | FA | 147 | 2.24E-02 | 0.043 | |
PCR | FA | 147 | 2.05E-02 | 0.032 | |
SM/Cer C24:1 | |||||
ACR | MD | 148 | −7.05E-05 | 0.033 | |
IFOF | MD | 148 | −8.68E-05 | 0.023 |
For each lipid outcome, only the diffusion measure from each white matter region that was significant at p<0.05 is displayed. The model adjusted for baseline age, sex, interval between blood draw and DTI, diabetes, BMI, scanner, and ratio of white matter lesions to intracranial volume. Corresponding p-values are shown and asterisks indicate associations survive FDR p<0.05.